By Rick Winterson Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge. It has now established its global headquarters on Fan Pier in South ...
Hosted on MSN10mon
A decade after sparking the Seaport’s boom, Vertex is considering leaving Fan PierBoston's most valuable biotech? Vertex. “As Vertex scales for future ... it would leave a huge chunk of empty lab and office space in the heart of the Seaport at a time when demand for such ...
The Boston drugmaker (Nasdaq: VRTX) says it put more than two decades of work into developing and bringing the new medicine to market. Stuart Arbuckle, Vertex’s chief operating officer ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.
The U.S. Food and Drug Administration said it approved Boston-based Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new ...
BOSTON, January 12, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the ...
The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex Pharmaceuticals. The drug, which is called suzetrigine and will be sold under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback